Free download The Organic Chemistry of Drug Design and Drug Action by Richard B. Silverman

3rd Edition

Authors of:  The Organic Chemistry of Drug Design and Drug Action by Richard B. Silverman

Richard B. Silverman

Mark W. Holladay

Table of Contents in The Organic Chemistry of Drug Design and Drug Action by Richard B. Silverman

Chapter 1 provides an introductory overview of the foundational concepts in drug discovery and development, setting the stage for deeper explorations into various scientific processes. This chapter lays out the essential terminology, principles, and goals that guide the entire process of designing, discovering, and optimizing therapeutic agents. It acts as a primer for readers unfamiliar with the intricacies of pharmacology and drug development, while also framing the broader context for the subsequent chapters.

Chapter 2 delves into the critical stages of lead discovery and lead modification. The process of lead discovery involves identifying potential molecules that could serve as a starting point for developing a new drug. This often involves screening large libraries of chemical compounds to identify promising candidates. Once a lead compound is identified, it undergoes various modifications to improve its efficacy, selectivity, and pharmacokinetic properties. The chapter explores different methods used in lead identification, including high-throughput screening, structure-based drug design, and computer-aided drug discovery. Additionally, the modification process is essential for optimizing a drug’s properties, ensuring it can effectively interact with biological targets while minimizing side effects.

Chapter 3 focuses on receptors, which are key biological structures that drugs target to produce therapeutic effects. Receptors are typically proteins that reside on the surface of cells and respond to external signals, such as hormones or neurotransmitters. This chapter explains how drugs interact with these receptors, leading to various physiological responses. The discussion covers different types of receptors, including G protein-coupled receptors (GPCRs), ion channels, and nuclear receptors. The chapter also examines how understanding the structure and function of receptors is vital for the development of selective and potent drugs.

Chapter 4 is dedicated to enzymes, which are proteins that catalyze biochemical reactions in the body. Enzymes are crucial in regulating metabolic pathways, and drugs often target these enzymes to alter their activity, leading to therapeutic outcomes. This chapter discusses the role of enzymes in disease processes and how they can be exploited as drug targets. It also provides insights into the structure of enzymes and the mechanisms by which they catalyze reactions, enabling drug developers to design inhibitors that can modulate enzyme activity for therapeutic benefit.

Chapter 5 expands on enzyme inhibition and inactivation, exploring how drugs can be designed to block or reduce the activity of specific enzymes. This is a critical strategy in drug development, as many diseases are associated with abnormal enzyme activity. By inhibiting the function of these enzymes, drugs can help restore normal physiological conditions. The chapter distinguishes between reversible and irreversible enzyme inhibitors, explaining their respective mechanisms of action. It also introduces the concept of enzyme inactivation, where drugs permanently disable enzyme function, leading to prolonged therapeutic effects.

Chapter 6 shifts the focus to DNA-interactive agents, a class of drugs that interact directly with DNA to alter gene expression or inhibit the replication of genetic material. These agents are particularly relevant in the treatment of cancer and viral infections, where targeting DNA can disrupt the proliferation of malignant or infected cells. This chapter explores different types of DNA-interactive drugs, including alkylating agents, intercalating agents, and topoisomerase inhibitors, each with distinct mechanisms of action. It also discusses the challenges and potential side effects associated with targeting DNA, as this approach can sometimes affect normal, healthy cells.

Chapter 7 addresses drug resistance and drug synergism, two critical concepts in pharmacology. Drug resistance occurs when a patient’s body or a pathogen becomes less responsive to a drug over time, diminishing the drug’s effectiveness. This phenomenon is particularly prevalent in the treatment of infectious diseases and cancer, where cells or organisms develop mechanisms to evade the effects of therapeutic agents. The chapter explores the biological mechanisms underlying drug resistance and strategies for overcoming it. Drug synergism, on the other hand, refers to the use of multiple drugs in combination to achieve a greater therapeutic effect than would be possible with a single drug. This approach can enhance treatment outcomes, reduce drug dosages, and minimize side effects.

Chapter 8 explores drug metabolism, a crucial aspect of pharmacokinetics that determines how a drug is processed by the body. After administration, drugs undergo metabolic transformations, primarily in the liver, to be converted into more water-soluble compounds that can be easily excreted. This chapter discusses the key enzymes involved in drug metabolism, such as the cytochrome P450 family, and how metabolic pathways can influence drug efficacy and safety. The chapter also highlights how understanding drug metabolism is vital for predicting potential drug interactions and optimizing dosing regimens.

Chapter 9 discusses prodrugs and drug delivery systems, two strategies used to enhance the effectiveness and safety of therapeutic agents. A prodrug is an inactive form of a drug that is converted into its active form once inside the body. This approach can improve the drug’s solubility, absorption, or distribution, and reduce its toxicity. Drug delivery systems, on the other hand, focus on optimizing how a drug is transported to its target site in the body. This chapter explores different drug delivery technologies, such as liposomes, nanoparticles, and targeted delivery systems, which can increase the precision of drug action, reduce side effects, and enhance patient outcomes.

The appendix includes answers to chapter problems, providing readers with solutions to exercises and questions posed in the earlier sections of the book. This section serves as a valuable resource for students or professionals looking to test their understanding of the material covered throughout the text.

Finally, the index provides a comprehensive list of key terms, topics, and concepts discussed throughout the book, enabling readers to quickly locate specific information. This tool is particularly useful for reference purposes, ensuring that readers can easily navigate the text and find relevant content efficiently.

Each chapter builds on the next, providing a structured and comprehensive guide to the field of drug discovery, design, and development. This cohesive approach ensures that readers gain a full understanding of the scientific principles and techniques essential to creating effective therapeutic agents.

File Size: 17.7 MB. Pages: 521 Please read Disclaimer.

Free download The Organic Chemistry of Drug Design and Drug Action by Richard B. Silverman

Download Link

You may also like to download “Organic Chemistry 10th Global Ed. By Leroy G. Wade And Jan William Simek”.

Free download hundreds of chemistry books in pdf from HERE.

Please Subscribe to our Email list and get notified of our latest uploads (Books, documents) and new updates. Email Subscription Box is provided on the sidebar (for PC) and on the bottom of this post (for Android Devices).

Kindly Like, Follow, and Share our social media pages so that the maximum number of people can benefit from this public service!

Facebook   Instagram    LinkedIn    Twitter    Pinterest

P.S: If the download link(s) is/are not working, kindly drop a comment below, so we’ll update the download link for you.

Happy reading!